Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

FLUMAZENIL KABI SOLUTION FOR INJECTION OR INFUSION 0.1MG/ML

Approval Number

SIN15610P

Drug Name

FLUMAZENIL KABI SOLUTION FOR INJECTION OR INFUSION 0.1MG/ML

Product Name

FLUMAZENIL KABI SOLUTION FOR INJECTION OR INFUSION 0.1MG/ML

Approval Date

January 9, 2019

Registrant

FRESENIUS KABI (SINGAPORE) PTE LTD

Licence Holder

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

Registrant

FRESENIUS KABI (SINGAPORE) PTE LTD

Licence Holder

FRESENIUS KABI (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

V03AB25

ATC Item Name

flumazenil

Manufacturer Information

Pharmaceutical Manufacturer

FRESENIUS KABI (SINGAPORE) PTE LTD

Manufacturers

Fresenius Kabi Austria GmbH

Active Ingredients

Ingredient Name

FLUMAZENIL

Strength

0.1mg/ml

Drug MonographFlumazenil

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy